Overview

Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers

Status:
Completed
Trial end date:
2008-08-17
Target enrollment:
Participant gender:
Summary
This study is designed to show bioequivalence between Current and New formulation of Aciclovir cream 5% in keratin layer of the epidermis in Japanese Subjects
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Acyclovir